Cannabis Sciences received amazing feedback on its launch of capsule products in the California market, and its subsidiary, Equi-Pharm, now has an online e-commerce website available throughout the nation for animal care products.
Cannabis Science managed to receive positive feedback from the consumers on its recently launched capsule product. The pharmaceutical company has plans of utilizing consumer data to manufacture and develop products while motivating customers to join Patient Access Center. Its exclusively owned subsidiary, Equi-Pharm, also made reports of launching its own online website, which will now provide convenience to customers, by allowing them to purchase animal care products online.
Cannabis Science’s subsidiary, Equi-Pharm, will provide the opportunity to pet owners to purchase goods for their pets online now through the firm’s online website. Products such as Hemp infused for horse owners will be available for shipment and purchase from its facility situated in Shelbyville, TN. This allows the animal care products business to reach a wider audience throughout the Nation. This is the perfect time for the business to launch its own website, because e-commerce is becoming widely common and growing in terms of sales and preference throughout the world.
The US drug organization is changing its business strategy by taking the comment and thoughts of its customers into account to further develop innovative products for them. The strategy is good because the company will be well aware of its customers’ preference, desire and demand, which will further help it to know its customers well and predict future demand. It recently reported to achieve amazing feedback on its launch of capsule products that were sold in California market.
The CEO of Cannabis Science, Raymond Dabney, confirmed this on Thursday in statement, “Our initial California test market has consumers giving us some amazing feedback to be combined with our proprietary information. We understand the value in using as much real consumer evidence in our drug development program as possible.”
The positive response achieved from the consumers has motivated the business to develop innovative and helpful drugs in future. Customers through the CBRF website can join the Patient Access Center (PAC) after which, they can put in their experiences and opinions on the website, which will be then analyzed and used in the development program of the organization.
The test marketing so far proved to be successful for the company. Through the opinions of the customers, its drug development department will get help and even the clinical research will be more effective due to awareness about customers’ preferences and demand insights.
Cannabis stock closed at $0.0121, going red by 9.02% on January 19.
Facebook latest News 